![](https://pharmaphorum.com/sites/default/files/2024-08/Bayer_Bill_Anderson.jpg)
Bayer CEO says recovery on track as key drug products shine
Bayer has joined its peers among European drugmakers with a hike in pharma forecasts for the year, as it recorded a rise in group sales, but lower profits for the second quarter. Total revenues came in at €11.1 billion ($12.2 billion) in the quarter, ahead …